Andrew Vincent
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study
Jörger M, Beijnen J, Huitema A, Vincent A, Smits P, Doodeman V, Bard M, Haitjema T, Smit E, Baas P, Burgers S, Schellens J. Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. Cancer 2011; 118:2466-75.
Sep 28, 2011Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study
Sep 28, 2011Cancer 2011; 118:2466-75
Jörger Markus, Beijnen Jos H, Huitema Alwin D R, Vincent Andrew, Smits Paul H M, Doodeman Valerie D, Bard Martin P L, Haitjema Tjeerd J, Smit Egbert F, Baas Paul, Burgers Sjaak A, Schellens Jan H M
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Smit E, van Zandwijk N, Vincent A, Schellens J, Jörger M, Dingemans A, Eppinga P, Smit H, Biesma B, Burgers S, Groen H. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45.
Apr 20, 2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer
Apr 20, 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:2038-45
Smit Egbert F, van Zandwijk Nico, Vincent Andrew, Schellens Jan H, Jörger Markus, Dingemans Anne-Marie C, Eppinga Pier, Smit Hans J M, Biesma Bonne, Burgers Sjaak A, Groen Harry J M